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(67%) had a minor infarct (25% of cortex), 9 (16%)
moderate (25-50% of cortex), and 2 (4%) severe (50%
of cortex). All but one patient were treated nonopera-
tively, using anticoagulation in 36 patients (86%) for a
mean duration of 5.7 months (range 1-24), life-long
aspirin therapy in 29 (69%), and blood pressure control
in 35 (83%). An attempt at ex-vivo repair in the operative
patient failed. Thirty-four patients (81%) developed new
onset of HTN within 1 year and were on 1.1 (range, 0-3)
antihypertensive medications at 1 year. Three patients
(7%) had a recurrent dissection, 41 (98%) had a normal
creatinine, and no patient died or required dialysis over a
mean follow-up of 35 months (range 0-279).
Conclusions: Nonoperative management of ISDRA is
feasible and safe in most patients.
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Objectives: Critical limb ischemia is associated with
skeletal muscle damage and tissue loss, however its patho-
physiology is poorly understood. Toll-like receptors
(TLRs) have been implicated in iscaemia-induced tissue
damage. TLR 2 & 6 in particular have been implicated in
critically ischemic muscle. Two separate signalling path-
ways exist for the signalling transduction of TLRs: the
MyD88-dependent pathway and the MyD88-independen
pathway. We aim to investigate which TLR signalling path-
ways are involved in ischemia-induced muscle damage. We
hypothesize that skeletal muscle ischemia induces TLR 2&
6 heterodimerisation and activation of the MyD88 depen-
dent pathway resulting in cytokine-mediated muscle
damage.
Methods: TLR 2 and 6 expression in ischemic and
control human muscle biopsies and in C2C12 myotubes
cultured in ischemic conditions were studied usingWestern
blot and immunohistochemistry. TLR 2& 6 heterodimeri-
sation was confirmed by co-immunoprecipitation. Func-
tional effects of TLR 2/6 and MyD88 antagonism on
ischemia-induced IL-6 release and apoptosis were studied
with neutralizing TLR 2/6 antibodies and aMyD88 inhib-
itor. IL-6 release was assayed by ELISA and apoptosis was
assessed using cleaved caspase-3.
Results: TLR 2 and 6 protein expression was signif-
icantly upregulated in ischemic muscle and ischemic
C2C12 myotubes (P.05). TLR 2 and 6 heterodimerise
under ischemic conditions with consequent activation of
the signaling pathway. Ischemia-induced IL-6 produc-
tion and apoptosis were reduced by TLR 2/6 antago-
nism and MyD88 inhibition.
Conclusions:Upregulation of TLR 2 and 6 expression
occurs in CLI. Heterodimerisation of TLR 2 and TLR 6
and the subsequent activation of the signaling pathway
results in IL-6 release and apoptosis which contributes to
inflammation and muscle damage in ischemia. Further we
have provided novel evidence that the MyD88 dependent
pathway is critical in the signalling process and maybe a
potential therapeutic target.
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Objectives: Despite advancements in renal replace-
ment therapy, mortality with acute kidney injury(AKI)
remains high, likely due to remote organ injury. Kidney
ischemia-reperfusion injury(IRI) activates cellular and soluble
mediators, driving lung inflammation, TNFR1-mediated ap-
optosis and microvascular barrier dysfunction. We hypothe-
sized that lung microvascular endothelial cells(ECs), with
their integral role maintaining the lung semipermeable bar-
rier, were key cellular targets of TNFR1-mediated apoptosis
during ischemic AKI.
Methods: Male C57/BL6 mice and Sprague-Dawley
rats underwent 60min bilateral renal pedicle occlusion(IRI)
or sham laparotomy(sham) and sacrifice at 4 or 24hrs.
TUNEL/DAPI/CD34 colocalization identified EC apo-
ptosis in vivo and ECs[CD45-/CD31] isolated by novel
techniques underwent RT-PCR Apoptosis SuperArray
analysis. In parallel, rat lung microvascular ECs(RLM-
VECs) treated with serum from rats after sham or IRI
underwent custom RT-PCR analysis for apoptosis and
TNF family gene transcription; capase-3 and PARP activity
assays identified RLMVEC apoptosis. Separately, inflam-
matory genes and apoptosis were compared in RLMVECs
treated with TNF/TNFR1 signaling inhibition (Etaner-
cept vs vehicle) during ischemic AKI.
Results: In vivo, TUNEL cells colocalized with
CD34 during ischemic AKI and isolated lung ECs demon-
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strated a proapoptotic transcriptome. In vitro, ischemic
AKI activated apoptosis (FasL,Dapk1,Bcl10) and TNF
family (TNFR1,TNFR2,TNF) genes, caspase-3 (100 
1.1 vs 106.5  0.8, P  .00325), and PARP (10  3.5 vs
61.8  20.5, P  .047) vs sham. Etanercept inhibited
RLMVEC inflammatory genes (E-Selectin, ICAM-1, IL-6,
RhoB), caspase-3 activity (100  0.9 vs 102  0.5, P 
.096) and PARP activity (10  2.3 vs 10.9  2.2, P 
.783) vs vehicle during ischemic AKI.
Conclusions: Ischemic AKI drives a proinflammatory
and proapoptotic lung EC transcriptome with TNFR1-
dependent apoptosis. Further study of EC-specific mecha-
nisms of kidney-lung crosstalk during AKI may identify
potential therapeutic targets.
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Adipose-Derived Stem Cells from Diabetic Patients as
Endothelial Cell Substitutes in Vascular Tissue Engi-
neering
Aleksandra Policha1, Ping Zhang1, Bing Shue2, Amanda
Smolock2, Lily Chang2, Masaya Jimbo2, Thomas Tu-
lenko3, Neil Moudgill4, Anumeha Whisenhunt4, Atul
Rao4, Joshua Eisenberg4, Paul DiMuzio4. 1Thomas Jeffer-
son University Hospital, Department of General Surgery,
Philadelphia, PA; 2JeffersonMedical College, Philadelphia,
PA; 3Cooper University Hospital, Camden, NJ; 4Thomas
Jefferson University Hospital, Department of General Sur-
gery, Division of Vascular and Endovascular Surgery, Phil-
adelphia, PA
Objectives: Surgical bypass and dialysis access cre-
ation are common procedures performed in diabetic
patients. Only 45% of patients have autologous vascular
tissue available for use as a conduit for these procedures.
We have developed an alternative conduit composed of a
vascular scaffold seeded with autologous adipose-derived
stem cells (ASC) differentiated into endothelial cells
(EC) to create a non-thrombogenic lumen. Herein, we
examine ASC from diabetic (DM) versus non-diabetics
(NDM) patients in terms of isolation efficiency, prolifer-
ation, commitment towards EC lineage, and seeding
onto a vascular scaffold.
Methods: ASC were isolated from peri-umbilical li-
posuction specimens by collagenase dispersion (DM
n53; NDM n145). Isolation efficiency was defined
by number of ASC isolated per gram of adipose tissue.
Proliferation was assessed by constructing growth curves over
14d. ASC were differentiated in endothelial growth medium
for 3wk. Differentiation was determined by measuring EC-
specific gene expression (CD31, vWF) using qPCR. Lastly,
ASC were seeded onto decellularized vein, flow conditioned
from 0-9 dynes over 5d, and examined using confocal
microscopy.
Results: ASC isolation efficiency did not differ be-
tween DM and NDM patients (224,028 cells/gm vs.
259,345 cells/gm, respectively; P  .21). The growth
curves for DM (n6) and NDM (n6) ASC also ap-
peared similar, with no significant differences observed
in cells counts between days 1-14. After 1, 2, and 3wk in
culture, no significant difference in CD31 or vWF ex-
pression between DM (n6) and NDM (n6) cells was
observed. Finally, retention of ASC to vascular scaffolds
under physiological shear stress was similar between the
two groups.
Conclusions: ASC are isolated from diabetics in
quantities similar to non-diabetics. These cells grow at
similar rates, exhibit differentiation into an EC pheno-
type, and line the lumen of a tissue engineered vascular
graft.
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Objectives: Intimal hyperplasia (IH) is the cause of
most failed arterio-venous fistulae (AVF), resulting in
repeat procedures and leading to increased utilization of
scarce health care resources. Our lab has previously demon-
strated the role of supplemental oxygen (O2) in preventing IH
and smooth muscle cell proliferation (SMCp) at an artery to
graft anastomosis and at the deployment site of an intra-
arterial stent. This study is to examine the effect of supplemen-
tal O2 in preventing IH and SMCp at an AVF in a rabbit
model.
Methods: 96 rabbits were randomized into three
groups: Group 1- control; Group 2- AVF without sup-
plemental O2; and Group 3- AVF with supplemental O2.
Rabbits receiving supplemental O2 received 30% oxygen for
Table. Measurement of intimal hyperplasia at fistula sitea
Day 1 Day 21 Day 42 Day 90
GROUP 1 0.02 0.02 0.02 0.02
GROUP 2 0.02 0.103b 0.209b 0.257b
GROUP 3 0.02 0.049 0.033 0.006b
aRatio of area of intima/media
bP.05 when compared to Group 1
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